The government and private investors have agreed to deepen cooperation to fast-track local pharmaceutical production as ...

Oral semaglutide was approved by the FDA in December 2025 as a once-daily pill (25 mg), intended to limit excess body weight ...

Upslope Capital Management, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the ...

With more Chinese-developed innovative drugs entering both US and European markets, China's pharmaceutical sector is showing escalating prowess in innovation and global market penetration, said ...

TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in OmicInsight Corporation ...

Rounding up five deals in the pharma commercialization segment, and delving into trends driving that activity; a discussion ...

The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai ...

Johnson & Johnson unveils US$4bn build programme for pharmaceutical manufacturing in Pennsylvania and North Carolina ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Culminate H Labs Co-Founders Calixto Vallejo, and Juan Carlos Rodriguez are elevating human potential through science—showing ...

Pediatric-onset IBD is characterized by increasing incidence and prevalence, a comprehensive diagnostic workup, an extensive inflammatory phenotype compared to adult patients, and a risk of ...